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Abstract: Background: Stellera Chamaejasme is a perennial weed and is found across a wide geographic range. It is found  
inthe Altai of eastern Russia, northern China and Mongolia southwards and reaches as far as the western Himalayas of the 
Qinghai-Tibet and Yungui Plateaus. The dried roots of S. Chamaejasme are named “Rui-Xiang-Lang-Du” and 
this herb with toxic properties is widely used in Traditional Chinese Medicine for the treatment of various 
disorders. It is effective against dispelling phlegm by water and displays toxicity against insect pests. This review 
provides a comprehensive overview of the chemical composition and the pharmacological properties of S. 
Chamaejasme thus providing a better insight in its application in the prevention of human disease . Methods:  A 
comprehensive literature review was undertaken and the main chemical compounds found in S. Chamaejasme 
were identified on the basis of their chemical formula and structure. These included coumarins, lignans, 
diterpenes plus others, and their pharmacological properties were also summarized in detail.  
Results:  The main constituents of S. Chamaejasme included flavonoids, diterpenoids, coumarins, lignans plus other 
compounds. The pharmacological properties of these compounds displayed a wide spectrum and include anti-tumors, anti-
viral, anti-bacterial, anti-convulsive, anti-epileptic, insecticide, anti-inflammation, regulation of immunity etc. The 
diterpenoids were widely recognized as the constituent responsible for the anti-tumor effect. 
                   Conclusions:  A large number of studies conclude that S. Chamaejasme displays a wide spectrum of 
pharmacological activity with the anti-tumor activity being significant.  
 
Keywords: Stellera Chamaejasme, Chinese herbal medicine, Chemical compositions, Analytical method, Pharmacological activities, 
Toxicity. 
1. INTRODUCTION 
Stellera Chamaejasme (Thymelaeaceae) is derived from 
genus Stellera Linn and is represented by 48 genera and 650 
species, widely distributed in both hemispheres. Stellera Linn. 
is about 10 to 12 genus, is distributed in temperate regions east 
to west of Asia and  there are two species which are found in 
China, S. Chamaejasme and S. Formosana, respectively. S. 
Chamaejasme is a perennial weed with a wide geographic 
range and is found in the Altai of eastern Russia, northern 
China, and Mongolia southwards and as far as the western 
Himalayas of the Qinghai-Tibet and Yungui Plateaus [1]. It is 
mainly distributed in Qinghai, Gansu, Hebei, Inner Mongolia, 
Tibet, and Xinjiang in China. S. Chamaejasme is also known  
as the graceful jessamine herb (Inner Mongolia), steamed 
bread spend (Qinghai), chervil and laevigata (Hebei). It is 
recorded in the Shennong’s Classic of Materia Medcia as a 
well-known traditional Chinese herbal medicine. It is bitter, 
pungent, and poisonous, and can enter the channels of lung, 
spleen and liver. It displays  efficacy against dispeling phlegm 
by water and is lethal  against  
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insect pests. Its dried roots, named “Rui-Xiang-Lang-Du” in 
traditional Chinese medicine, have been used for the treatment 
of scrofula and neurodermatitis  and it has also been used as a 
traditional Chinese medicine formula for the clinical 
treatment of cancer, lymphatic structure, tuberculosis, skin 
diseases, and other diseases [2]. 
The chemical compositions of S. Chamaejasme is very 
complex. Previous phytochemical studies have reported  that 
the main compounds of interest isolated have been reported to 
be flavonoids, coumarins, lignans, diterpenes, sesquiterpenes, 
phenylpropanol glycosides, volatile oil, etc. Recent 
pharmacological studies show that S. Chamaejasme has anti-
viral, anti-bacterial, anti-convulsive, anti-epileptic, 
insecticide, anti-inflammation, regulation of immunity and 
various other biological activities. A study found that the 
flavonoid extract from S. Chamaejasme had strong in vivo and 
in vitro antitumor effects whilst total lignans had a strong 
antitumor effect in vitro. Coumarin compounds are 
characteristic of these components, not only does it have 
strong toxicity, it also has a wide range of pharmacological 
effects such as anti-HIV, anti-tumor, anti-oxidation, anti-
microbial, anti-pressure, anti-radiation etc. The diterpenoid 
gnidimacrin is widely recognized as the main component of 
the anti-tumor effect because of its strong anticancer activity 
[3]. Thus it can concluded from these studies that S. 
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Chamaejasme is of great medicinal value. This review 
comprehensively summarizes the chemical components and 
pharmacological activities of S. Chamaejasme and provides 
future directions for the the development and utilization of the 
plant for the treatment of diseases. 
2. CHEMICAL COMPOSITIONS 
Over the past few decades, studies on bioactive 
phytochemicals isolated from S. Chamaejasme have 
signicantly increased, and an increasing number of bioactive 
constituents have been discovered and reported. The major 
active constituents are flavonoids, coumarins, diterpenes, 
lignans, sesquiterpenes, phenylpropanol glycosides, volatile 
oils, as well as sterol, acid composition, amino acid, 
triterpenoid, resin etc.  
2.1 Flavonoids  
The flavonoids isolated from S. Chamaejasme are mainly 
dihydroflavones and chamaechromone compounds. A study 
confirmed that the contents of flavonoids in the leaf and root 
of S. Chamaejasme were 2.92% and 1.13%, the content of its 
leaves were higher than that of the the root [4]. A total number 
of 46 flavonoids were isolated from  S. Chamaejasme (Fig. 
1).and these were chamaejasmine (1) [5], 7-
methoxychamaejasmin (2) [5], ruixianglangdu B, A (3 and 
22) [6], chamaejasmine AE (4, 79, 13) [7-9], chamaejasmin 
D (14) [9], chamaeflavone A (15) [10], isochamaejasmin (5) 
[11]，neochamaejasmin AC (10, 16, and 17) [12, 13], 7-
methoxylneochaejasmin A (11) [14], sikokianin AC (12, 18, 
and 24) [9, 15]. isoneochamaejasmin A (19) [14], 
euchamaejasmin AC [16], isochamaejasmin B, C (20 and 21) 
[15, 17], isosikokianin A (23) [15] as well as mesomer 
isochamaejasmin [18]. 
Niwa separated chamaechromone (25) [19] from S. 
Chamaejasme in 1984 followed by isolations of mohsenone 
(26) and isomohsenone (27) [20]. The other flavonoids 
isolated were 3′,14-dimethyl-4′,11-dimethoxy-5,7-
dihydroxybenzene dihydroflavone (28), (−)-epiafzelechin-7-
O-β-D-glucopyranoside (29) [20], stelleranol (30) [14], 7-O-
β-D-glucopyranosyl-isochamaejasmin (6) [21], (+)-
epiafzelechin (31) [14], wikstrol A, B (32 and 33) [22], 
apigenin (34), quercetin (35), rutin (36) [15], 
dihydrokaempferol (37) [23], isoquercitrin (38) [24], 
daphnodorin B (39), dihydrodaphnodorin B (40), genkwanol 
A (41) [25], 4',5,7-trihydroxyflavanone (42) [26], 5,4'-
dyhydroxyl-7-methoxydihydroflavone (43), 3,5,7-
trihydroxyflavanone (44), 4'-methoxy-7-hydroxyflavone (45)
，kaempferol-7-O-β-D-glucoside (46) etc. [27].. The total 
flavonoid extracts are of great significance in the investigation 
of the anti-tumor effects in vivo and in vitro. 
2.2 Coumarins  
Coumarin compounds are a class of natural active 
substances with α-pyrone nuclear parent. They are one of the 
characteristic components of the thymelaeaceae plants with 
aromatic smell, and are also one of the important active 
constituents present in higher plants. Coumarin compounds 
are distributed in the roots and the above-ground parts of S. 
Chamaejasme. The components that have been isolated from 
the S. Chamaejasme were all the umbelliferone derivatives. A 
total of 19 coumarins were reported from S. Chamaejasme 
(Fig. 2). They were sphondin (47), isobergapten (48), 
pimpinellin (49), isopimpinellin (50) [28], umbelliferone (51), 
daphnetin (52), scopoletin (53) [29], daphnin (54) [8], 5,7-
dihydroxycoumarin (55) [30], daphnoretin (56), 
chamaejasmoside (57) [12], isodaphnoretin (58) [31], 
isodaphnoretin B (59) [15], O-[β-D-xylopyranosyl (1→6)-β-
D-glucopyranosyl]-7-hydroxycoumarin (60) [32], 3-hydroxy-
6-methoxy-7,7'-dicoumarinyl ether (61) [33], 
bicoumastechamin (62) [34], daphnin (63), daphnetin-8-O-
glucoside (64) and rutarensin (65) [24]. Coumarins act as a 
phytohormone in plants and they are the most toxic type of 
phenolic compounds, and they play an important role in the 
growth and development of plants and against the invasion of 
foreign bodies [35]. 
2.3 Lignans  
Lignans are a kind of natural compounds which are formed 
by the oxidation of phenylpropanoids, and most of them are 
of furan or tetrahydrofuran structure. The total lignans in S. 
Chamaejasme significantly inhibited the tumor cells in vitro 
[36], and the antitumor activity was higher than that of 
vincristine. At present there are 30 lignans which have been 
isolated from S. Chamaejasme (Fig. 3). Among them, were 
lirioresinol B displaying ichthyism activity (66), pinoresinol 
(67) [37] and matairesinol (70) [37]. Eudesmin displaying 
anti-HIV activity was also isolated (71) [16]. Other lignin 
compounds were (−)-eudesmin (68) [38], syringaresinol di-O-
β-D-glucopyranoside (69) [39], bursehernin (72) [14], lappaol 
F (73) [40], arctiin (74) [40], magnolenin C (75) [41], 
isohinokinin (76) [41], demethyl-trachelogenin (77), 
isolariciresinol (78), (+)-secoisolariciresinol (79) [42], (+)-
lariciresinol-4,4'-O-bis-β-D-glucopyranoside (80) [43], (−)-
haplomyrfolin (81) [44], stelleralignan (82) [44], two new 
neolignans named (−)-(7R,8S,7′E)-4-hydroxy-3,5′-
dimethoxy-7,4′-epoxy-8,3′-neolign-7′-ene-9,9′-diol 9′-ethyl 
ether and (−)-(7R,8S,7′E)-4-hydroxy-3,5,5′-trimethoxy-7,4′-
epoxy-8,3′-neolign-7′-ene-9,9′-diol 9′-ethyl ether (83 and 84) 
[45], stellerachama A (85) [46], syringaresinol (86), (−)-
medioresinol (87), (−)-pinoresinol (88), epipinoresinol (89), 
caruilignan D (90), (−)-lariciresinol (91), 5′-
methoxylariciresinol (92), 7′-oxomatairesinol (93), (+)-
guayarol (94), acutissimalignan B (95) [47] etc. 
2.4 Diterpenes 
There were varieties of diterpenes isolated from S. 
Chamaejasme with significant pharmacology activity. To 
date, 37 diterpenes have been reported from S. Chamaejasme 
(Fig. 4). In 1982, Niwa found four diterpenes with antitumor 
activity based on ichthyism activity, they were huratoxin (96), 
subtoxin A (97), simplexin (98), and pimelea factor P2 (100) 
[37]. In 1992, Feng found a strong anti-pain active ingredient 
named gnidimacrin(101) [48] for the first time in the root of 
the plant. Following this the compounds of stelleramacrin B 
(99) and stelleramacrin A (102) [49] were isolated. These 
compounds represent rare diterpene original acid esters 
compounds found in nature. The other diterpenoids were 
neostellerin AC (103105), neostellin (106) [16], 
neostellerin (107) [14], a new daphnane-type diterpene (108) 
[32], wikstroelide F (109) [50], stelleralides AC (110112) 
[51], stelleralides DJ (113119) [52], pimelotide A (120) 
  
[53], wikstroelide A, B (121 and 122) [50], wikstrotoxin A 
(123) [54], wikstroelide M and J (124 and 125) [50], 
stellerarin (126), 12-O-benzoylphorbol 13-octanoate (127), 
stelleracins AE (128132) [10] etc. Many studies have 
shown that the diterpenoids have strong biological activity 
especially against cancer and HIV.  
2.5 Sesquiterpenes 
There were  8 sesquiterpenes which were isolated from S. 
Chamaejasme (Fig. 5), these were 3-oxo-guai-4-ene-11,12-
diol (133), (+)-(11S)-3-oxo-1,7αH-guai-4-en-11,12-diol 
(134), (+)-(11S)-3-oxo-1,7αH-guai-4-en-10α,12-diol (135), 
(+)-3-oxo-1,7αH-guai-4(5),11(13)-dien-10α,12-diol (136), 
chamaejasmone AC (137139) [45], chamaejasmone D 
(140) [44]. 
2.6 Volatile oils 
There were 22 species of volatile oils isolated from the root 
of S. Chamaejasme, namely ethyl acetate, caprylic aldehyde, 
13-myrcene, neral, 5-methyl decane, 3,7,11-trimethyl-12-
carbon-α-trans-6,6-cis-10-enol, etc. [55]. Another 18 
constituents were also identified from volatile oils of S. 
Chamaejasme [56], and included 7 kinds of ketone 
compounds, 3 kinds of alcohols, 2 kinds of alkanes and 
amides, and one type of esters, aldehydes, acetylene and acids. 
In addition, the volatile oils of two rare amide-hydrazine 
diphenylamine and acetanilide were also found in the leaf of 
S. Chamaejasme, and the former had a quality score of 
17.26%, so these two compounds are likely to be the source 
of the distinctive pungent odour of S. Chamaejasme leaves 
[55]. 
2.7 Other components 
Besides containing flavonoids, coumarins, diterpenes, 
lignans, phenylpropanol glycosides, and volatile oils S. 
Chamaejasmealso contain sterol, amino acids, triterpene, 
sesquiterpene, resin, saponins, tannins, polysaccharides, the 
toxic macromolecule organic acid and other constituents [57]. 
The monosaccharide content was 1.37%, the polysaccharide 
was 43.13%, it contained sucrose, fructose, glucose and  
flavonoid glycoside [58]. The14 compounds found in S. 
Chamaejasme are summarized in Fig. 6. In 1999 there were 6 
phenylpropanol glycosides isolated for the first time [59], and 
these were coniferinoside (141), syringin (142), syringinoside 
(143), sinapylalc-1,3-diglucopyranoside (144), 4-(-β-D-
glucopyranosyloxy-1-E-propenyl-2,6-dimethoxyphenyl-6-O-
β-D-glucopyranosyl-β-D-glucopyranoside (145), and 4-(3-
hydroxy-1-Z-propenyl)-2,6- dimethoxyphenyl-6-D-
glucopyranosyl-β-D-glucopyranoside (146). The other 
compounds isolated from the plant were β-sitosterol (147), 
daucosterol (148), stigmasterol-4-alkene-3,6-diketone (149), 
rel-(−)-(3R,3'R,4R,4'R)-6,6'-dimethoxy-[3,3'-bichroman]-
4,4'-diol (150), methyl 3-(2-hydroxy-4-((7-hydroxy-6-
methoxy-2-oxo-2H-chromen-3-yl)oxy)phenyl) propanoate 
(151) [42], 1,5-diphenyl-1-pentanone (152),   1,5-diphenyl-2-
alkene-1-pentanone (153) [60], (+)-S-1,5-diphenyl-3-
hydroxy-1-pentanone (154) etc. [61].  
3. ANALYTICAL METHOD 
There were four flavonoids isolated from the root of S. 
Chamaejasme by silica column chromatography, which were 
identified as neochamaejasmin, epiafzelechin, 
chamaechromone and wikstrol [62]. The root of S. 
Chamaejasme ethanol extract, petroleum ether extract and 
chloroform extract was used for further separation by using 
the method of active tracking. β-sitosterin was isolated from 
the petroleum ether extract; three active components were also 
isolated from chloroform extract and were identified as  
umbelliferone, daphne pavilion and chamaechromone 
respectively[63]. Various methods were used to extract 
flavonoids from S. Chamaejasme and the content of 
flavonoids was determined by spectrophotometer. It has been 
reported that the ultrasonic extraction method was the best and 
the content of the flavonoids was the highest in the polyamide 
resin column chromatography [64]. The extraction of S. 
Chamaejasme by quenching with ultrasonic extraction and 
solvent extraction method, resulted in  the extraction ratio of 
total flavonoids being high, and the the utilization rate of raw 
material was obviously higher and the costs were lower when 
compared to other methods ; this method is  suitable for a large 
number of extractions [65]. Using ultrasonic technology total 
flavonoids exytacted from S. Chamaejasme, were 24.3%. 
Also the flavonoids of S. Chamaejasme displayed significant 
ability to remove superoxide anion free radical and hydroxyl 
free radical in vitro, its effect was stronger than VC [66]. 
The content of coumarins of S. Chamaejasme was 
determined by ultrasonic extraction and spectrophotometry, 
The content of coumarins were significantly different in the 
nutritive organs, the highest concentration was found in the 
root, and lowest in the leaves and stems [35].  Reversed-
phase high performance liquid chromatography (HPLC) was 
used to establish the content of 7,8-dihydroxy coumarin in 
the root, stem, leaf and flower of S. Chamaejasme and at the 
same time diode array detector was used to confirm the 
purity of the standard  and the plant extracts and ultraviolet 
spectrum identification  was also used. This method is 
simple, accurate and reproducible, and it is suitable for the 
quality evaluation of drugs and herbs containing this 
component [67]. . This method is simple, accurate and 
reproducible, and it is suitable for the evaluation of the 
quality of drugs and herbs containing this component [67]. 
The response surface method of extraction pressure was 
30MPa, extraction temperature was 53C  and the volume of 
ethanol was 3 mL/g and under these conditions the total 
yield of coumarins was 0.36%, which is very close to the 
theoretical yield. This proves that  the optimized extraction 
process parameters obtained by the response surface method 
was accurate and reliable and was of practical value [68]. A 
chromatographic method was used to identify the chemical 
structure of the components of the monomers. The multiple 
lignin compounds were isolated from the root of the S. 
Chamaejasme, and four of them were identified as lappaol F, 
clemastanin B, arctiin and matairesinol [40]. 
 
 
There were four kinds of rexane diterpenes with anticancer 
activity which were isolated from methanol extract of S. 
Chamaejasme, they were huratoxin, subtoxin A, simplexin, 
  
and pimelea factor P2 respectively [37]. The components of 
volatile oils separated from the root of S. Chamaejasme were 
analyzed by gas-uality combined method, including ethyl 
acetate, octal, 13-laurene, neral, 5-methyldecane, etc. [55]. 
The quantitative analysis and comparison of total saponins 
and tannins of S. Chamaejasme were performed by means of 
weight method and complexation titration. The content of the 
total saponins and tannins were 2.75% and 3.62% respectively 
[69]. 
4. PHARMACOLOGICAL ACTIVITY 
4.1 Anti-tumor activity 
4.1.1 Anti-liver cancer activity 
The medicated mice serum containing S. Chamaejasme 
could significantly increased anti-cancer activity of 
adriamycin and cytarabine resistant in human liver cells Bel5-
FU2000 in a concentration-dependent manner [70]. After 
comparing the inhibitory effects of different S. Chamaejasme 
extracts on liver cancer cells (SMMC-7721), the results 
showed that the total flavonoid extract presented the strongest 
in vitro antitumor activity [71]. The efficacy component 
Zp1111 of S. Chamaejasme had a good inhibitory effect on 
liver cancer cells HepG2, BEL-7402, and SMMC-7721 
cultured in vitro, with the IC50 37.75, 28.60, 29.22 μg/mL, 
respectively, while the inhibitory effect was not obvious in 
normal hepatocellular LO2. Zp1111 induced apoptosis of bel-
7402 cells, controlled the distribution of bel-7402 cell cycle in 
vitro culture, reduced the cell proportion of S stage, and had a 
better inhibitory effect on protein kinase cyclin-dependent 
kinases (CDK2) [72]. The water extract of S. Chamaejasme 
(SCLA) was observed to prolong survival time of liver cancer 
H22 tumor-burdened mice in the low dose group, suggesting 
that SCLA had a significant inhibitory effect on liver cancer 
[73].  
4.1.2 Anti-lung cancer activity 
After treatment of lung cancer cell lines by SCLA, 
immunohistochemical SP method was used to detect gene 
expression of multi-resistant related protein (MDM2), lung 
resistance protein (LRP), heat shock protein 27 (HSP27), and 
multi-drug resistance (MDR-1). The positive rate and 
brightness of MDR-1, LRP, and MDM2 of the NCI-h446 cells 
were significantly decreased, while the expression of HSP27 
was not significantly different (P > 0.05); the positive rate and 
brightness of MDR-1, LRP, and HSP27 of the NCI-H157 cell 
were obviously depressed (P < 0.05), while the expression of 
MDM2 did not change significantly (P > 0.05), when 
compared with the control group. These results indicate that 
SCLA had obvious inhibitory effects on the expression of 
some gene proteins in lung cancer cell lines [74]. The 
flavonoids extract of S. Chamaejasme (ESC) displayed 
inhibitory effect on human lung cancer cell line NCI-H157. It 
had significant cytotoxicity to NCI-H157 cell, with IC50 of 
approximately 18.50 g/mL-1. ESC caused an obvious increase 
in total apoptosis rate, and the activity of caspase-3 and -8 as 
well as the expression of Fas protein was significantly 
enhanced (P < 0.05), it is likely that the inhibitory effect was 
caused by activation of Fas death receptor pathway [75]. The 
flavonoid extract from S. Chamaejasme was able to inhibit the 
proliferation of A549 cells, showing a significant time-dose 
dependence. The total flavonoid extract also induced 
apoptosis of A549 cell and blocked A549 cell in G1 phase 
[76]. Chamaejasmine B and neochamaejasmin C were 
potential anti-proliferative compounds isolated from S. 
Chamaejasme, which had significant anti-tumor efficacy in 
sensitive human lung cancer A549 cell line. The IC50 of 
chamaejasmenin B and neochamaejasmin C were 1.08 
μmol/L and 5.72 μmol/L, respectively, indicating that 
chamaejasmenin B had a slightly higher cytotoxic effect on 
A549 cell than neochamaejasmin C. The two compounds 
induced significant expression of DNA damage marker γ-
H2AΧ and apoptosis. In addition, G0/G1 phase was also 
remarkably suppressedand the protein level of Myeloid cell 
leukemia-1 (Mcl-1), a basic regulator of survival, was 
evidently reduced. After the treatment of chamaejasmine B, 
the expression of X Linked Inhibitor of Apoptosis Protein 
(XIAP) in A549 cells was decreased, indicating that 
Chamaejasmine B might induce double strand breaks (DSBs), 
activate apoptosis pathway, and produce anti-proliferation 
effect in A549 cells. Chamaejasmine B and neochamaejasmin 
C could be used as candidates for effective treatment of cancer 
[77]. S. Chamaejasme extracts ESC and ESC-2 possessed 
significant inhibitory effects on tumor cells NCI-H157 and 
NCI-H460 in vitro, with the order ESC-2 > ESC. ESC and 
ESC-2 greatly increased the apoptotic rate and caspase -3, -8 
enzyme activities in NCI-H460 cells. ESCs had no significant 
effects on expression of Fas and Fas-L proteins, but TNF-
α/TNFR1 protein expression significantly changed in NCI-
H460 cell after treatment with ESC and ESC-2 [78]. 
4.1.3 Antigastric cancer activity 
Diterpenoid compound gnidimacrin of S. Chamaejasme 
had a strong inhibitory effect on human gastric cell Kato-III. 
The IC50 was 0.00075 μg/mL in MTT and 0.002 μg/mL in the 
colony forming test of Kato-III cell under the action of the 
gnidimacrin; The IC50 was Ⅲ 0.044g/mL in MTT and 
0.05μg/mL in the colony forming test of Kato-III cell under 
the action of the adriamycin. Revealed that gnidimacrin had 
stronger inhibition of gastric cancer [79]. The multidrug 
resistance of cell line SGC7901/ADM could be reversed by 
SCLA. After adding 0.25 mg/mL adriamycin (ADM) (final 
concentration), the accumulation of ADM was significantly 
increased in the control group of SGC7901/ADM cells (P < 
0.05); and the expression of p-gp in the SCLA group was 
significantly lower than that in the control group (P < 0.05), 
suggesting that SCLA of 0.25 mg/mL could partly reverse the 
drug resistance of SGC7901/ADM cells to ADM, with the 
ratio of 2.54 times. The mechanism might be related to 
downregulation of the p-gp expression of SGC7901/ADM 
cell membrane, increasing of the intracellular ADM 
concentration, and activation of the apoptosis signaling 
pathways of caspase protein family [80]. 
4.1.4 Anti-bladder cancer activity 
The mice were given different doses of SCLA orallly, the 
serum was collected at different times and was exposed to 
human T24 bladder cancer cells cultured in vitro. The 
medicated serum collected after 2h of intragastric 
administration significantly reduced T24 cell proliferation, 
  
but the proliferation inhibition was weaker after collection of 
1h and 3h, which might be associated with different SCLA 
concentrations in the serum due to incomplete absorption 
[81]. SCLA could inhibit proliferation, promote apoptosis and 
lower the expression of survivin protein in bladder cancer T24 
cells in a concentrations and time-dependent manner [82]. 
SCLA also inhibited proliferation of biu-87 human bladder 
cancer cell (biu-87) and promoted apoptosis by restraining the 
expression of b-celllymphoma/leukemia-2 (bel-2) proteins. 
Furthermore, with the increase of drug concentration and the 
extension of time, the inhibitory effect on biu-87 cells was 
more obvious [83]. 
4.1.5 Anti-leukemia activity 
SCLA had a significant inhibitory effect on the growth and 
colony formation in P388 cells in vitro as SCLA significantly 
inhibited the growth of tumor cells at the concentration of 2 
mg·mL-1 [84]. The medicated mice serum of SCLA (520 
g·kg-1) markedly inhibited the proliferation of leukemia K562 
cells, induced the morphological changes and DNA changes 
in K562 cells. The apoptotic rate was positively correlated 
with the dose of SCLA [85]. SCLA medicated serum 
evidently reduced cell viability and clone formation rate in 
mice leukemia L1210 cells it also showed stronger proliferative 
inhibition in tumor cells, this direct inhibition of cancer cell 
proliferation and DNA synthesis is an important anticancer 
approach [86]. The ethanol extract of S. chamaejasme induced 
autophagy in chronic leukemia cells K562. After 72h of 
treatment at concentrations of 0.002–0.5%, the cell growth 
was inhibited dose dependently from 20 to 70% compared to 
the control group. 70% of autophagosome formation 
inhibition was detected after 24h of treatment with 0.2% 
extract treated cells, while the inhibitory rates were 35% and 
18%, respectively, at the extract concentrations of 0.02% and 
0.002%, suggesting that the anticancer effect of S. 
Chamaejasme could be related to induction of autophagy in 
malignant cells [87]. 
4.1.6 Anti-breast cancer activity 
Breast cancer is the second killer of womenand it is worth 
noting that more than 90 percent of patients with breast cancer 
were found to have tumor metastasis [88]  with a significant 
mortality of 80% [89]. SCLA displayed a dose-dependent 
cytotoxic effect on drug resistant cells (Mcrophge Colony 
Stimulting Fctor/Adriamycin) MCF-7/ADM. SCLA inhibited 
the MCF-7/ADM cell growth rate up to 95% at the 
concentration of 0.25 mg/mL and SCLA reversed the 
resistance of MCF-7/ADM cells to ADM up to 2.53 times (P 
< 0.05). The mechanism was probably related to reduction in 
the expression of the p-gp in the cell membrane and increase 
in the drug concentration of ADM in the cells, suggesting that 
SCLA is of great clinical value in treatment of breast cancer 
with refractory, recurrent and MDR high expression [90]. 
Chamaejasmine inhibited the proliferation of breast cancer 
mda-mb-231 cells by restraining G2/M and inducing cell 
apoptosis.  It reduced the levels of WAF1/p21, kip1/p27, 
cycloelement A, cycloelement B1, cell dependent kinase 
(CDK) 2 and cdc2 in mda-mb-231 cells. The nuclear 
translocation, phosphorylation of NF-кb, activation of IKKα 
and IKKβ and degradation of IкBα were also suppressed by 
Chamaejasmine [91]. The known TGF-beta blockers exert 
little selectivity on its functions, indiscriminately causing the 
anti-metastatic and pro-growth effects. Under such 
circumstances, specifically rebalancing the oncological 
function of TGF-beta provides a crucial oncotarget against 
metastasis. Chamaejasmin B (CHB) extracted from S. 
Chamaejasme suppressed the migration and invasion in breast 
cancer cells in vitro. Moreover, by dynamical quantification 
of breast cancer progression using small-animal imaging 
system, CHB was proved to be a potent inhibitor of metastasis 
with minimal toxic side effects. CHB efficiently blocked 
TGF-beta induced EMT, disrupted the interaction between β3 
integrin-TβRII complexes and consequently resulted in the 
selective inhibition of FAK/Src/p38 pathway. It was not the 
universal blocker for TGF-beta. In contrast, the cytostatic 
effect of TGF-beta was significantly activated by CHB 
treatment, and as such, CHB re-balanced the functional output 
of “TGF Paradox” in tumor microenvironment. Collectively, 
owing to targeting TGF-beta Paradox, CHB could be a 
promising candidate for metastatic intervention [92]. 
4.1.7 Anti-MDR activity 
Multidrug resistance (MDR) is a major barrier to the 
effectiveness of cancer chemotherapy and finding new anti-
MDR drugs is an important way to overcome resistance to 
cancer drugs [93]. CHB could inhibit the growth of the 
sensitive and drug-resistant cell lines in vitro, while the 
average resistance factor (RF) of CHB was only 1.26. In 
addition, CHB showed good anti-MDR activity in xenograft 
mice KB and KBV200 cancer cells. Subsequent studies have 
shown that CHB resulted in the blockage of g0/g1 cell cycle 
and apoptosis in KB and in resistant KBV200 cancer cells. 
CHB had no influence on the level of Fas/FasL and activation 
of procaspase 8. However, CHB-induced apoptosis was 
dependent on the activation of caspase -9 and -3. Moreover, 
CHB treatment was responsible for the elevation of the 
Bax/Bcl-2 ratio, attenuation of mitochondrial membrane 
potential (ΔΨm), and release of cytochrome c and apoptosis-
inducing factor from mitochondria into cytoplasm both in KB 
and KBV200 cells. CHB had good anti-MDR activity in vitro 
and in vivo, and the underlying mechanism might be related 
to activation of mitochondrial apoptosis pathway. Currently 
there were no effective MDR reversal agents used in clinical 
treatment, and these findings for MDR treatment provide a 
new potential [94]. 
4.2 Antibacterial activity 
Human pathogenic bacteria include escherichia coli, 
staphylococcus aureus, candida albicans trichophyton 
rubrum, trichophyton gypseum, microsporum gypseum, 
epidermophyton floccosum and others. The ethyl acetate 
extract of S. Chamaejasme had inhibitory effects on common 
bacteria and fungi at 33.33 g/L concentrations with 
bacteriostatic ring diameter up to 12.02 mm in the bacteria 
group and up to 9.4 mm in the fungus group [95]. The 
antibacterial active substance was also found in the ethanol 
extract of S. Chamaejasme, the inhibitory effect on sclerotinia 
sclerotiorum, phytophthora capsici, alternaria solani and 
strawberry grey mould fungus were better. The antibacterial 
rates were all over 50%, specifically more than 80% for 
phytophthora capsici. Plant fungicide of natural origin which 
are safe to human and livestock, have many advantages, such 
  
as little environmental pollution, tough induction of drug 
resistance, easy degradation, etc. So looking for the 
bacteriostatic active substance from plants is one of the hot 
spots of development new fungicide, thus it is necessary to  
investigate S. Chamaejasme [96] further. The inhibitory effect 
of the ethyl acetate extract of S. Chamaejasme on the growth 
of magnaporthe oryzae was highly significant. The 
deformation of mycelium was observed under inverted 
microscope, and the cytoplasmic agglutination, separation of 
plasmolysis and organelle degradation were also found under 
transmission electron microscope. The acetate extract of S. 
Chamaejasme had a strong inhibitory effect on the 
germination and emergence of the rice blast spores, which 
could control the incidence of magnaporthe oryzae [97]. The 
ethanol extract of S. Chamaejasme leaf enlarged the diameter 
of  staphylococcus aureus up to 12.8 mm and the diameter of 
trichomycosis gypsum up to 12.0 mm at 100 mg/mL 
concentration, which was better than dichloromethane extract. 
The extract of S. Chamaejasme had stronger inhibitory 
activity against trichomycosis gypsum when compared to 
staphylococcus aureus. The extract might inhibit or interfere 
with the synthesis of bacterial cell walls to achieve the 
bacteriostatic effect [98]. 
4.3 Anti-HIV activity 
The MeOH extract stelleralide A−C from S. Chamaejasme 
were found to be high in anti-HIV activity with EC90 values 
of 0.50, 0.56, and 0.66 nM, respectively. They also 
demonstrated relatively low cytotoxicity (IC50 5.1, 4.4, and 
4.7 μM). Structurally, these three compounds differ only in 
the C-13 ester substituent [10]. The petroleum ether extract of 
roots of S. Chamaejasme named stelleralides F−H, 
gnidimacrin, and pimelea factor all exhibited extremely potent 
anti-HIV activity, with EC50 values were 0.93, 0.73, 0.98, 0.06, 
and 1.1 nM respectively and selectivity index values of more 
than 10 000. Structurally, the main difference between the 
most potent compound was in ring A, suggesting that the 
importance of a cyclopentane ring A for optimal anti-HIV 
activity [99]. 
4.4 Antiepileptic and anticonvulsant activity 
Epilepsy is a chronic paroxysm group with abnormal 
electrical activity of nerve cells  and patients need lifelong 
treatment in order to effectively control the condition. 
Traditional western medicine can’t effectively control the 
seizures, and furthermore patients have to tolerate the toxic 
side effects of the drugs for long periods of time. The acetone 
extract of S. Chamaejasme (AESC) had anti-convulsive 
effects on various acute and chronic experimental epilepsy 
models. AESC could increase the rat cortical convulsion 
thresholds of electrical stimulation (TLS) after gavage of 384 
mg/kg and intraperitoneal injection of 174 mg/kg, and the 
effect lasted for 710 d. In comparison, the effect of 
magnesium valproate injection duration is only 8h. AESC had 
a dose-dependent antagonistic effect on mice auditory 
convulsion (As), maximum electroconvulsive convulsion 
(MEs), and pentazole convulsions (MET), with ED50 of the 
anti-AS, anti-MES and anti-MET 103.05, 123.83 and 132.01 
mg/kg, respectively. AESC was also able to antagonise the 
marine alginate convulsions of the rats, significantly reducing 
the wet sample shivering (WDS) (P < 0.05), and effectively 
extending the convulsion latency (P < 0.05). AESC was 
effective in many animal convulsion models,  displaying long 
duration and high antiepileptic spectrum. Its action properties 
were similar to the magnesium valproate [100]. S. 
Chamaejasme acetone extract had strong antagonistic effect 
on the rats' maximal electroshork seizure test (MES), tetrazole 
convulsion experiment (MET) and threshold in a localized 
seizure (TLS) model, and the treatment index reached up to 
14.9 for the acetone extract with reduced toxicity. A 
promising antiepileptic drug with strong anticonvulsive effect 
and slight toxicity can possibly be developed from the acetone 
extract of S. Chamaejasme [101]. 
4.5 Anti-inflammatory activity  
S. Chamaejasme ethanol extract (SCE) displayed healing 
and anti-inflammatory effects on the full-thickness skin defect 
of the Sprague Dawley (SD) rats. In vivo, the wound size was 
reduced and epithelial cells were also improved after SCE 
treatment. In vitro, SCE could induce the migration of 
keratinocyte cells by regulating the chain cells, extracellular 
signal regulation kinase and Akt signaling pathway. SCE also 
increased the mRNA expression of I and III collagenin Hs68 
fibroblasts and inhibited the release of inflammatory 
mediators NO, prostaglandin E2 (PGE2) and mRNA 
expression in the original 264.7 macrophages. SCE enhanced 
the activity of black keratinocytes and promoted the healing 
of skin wounds in SD rats [24]. 
4.6 Immunocompetence 
S. Chamaejasme polysaccharide (RXLDDT) could 
improve the inhibitory effect of cyclophosphamide (CTX) on 
immune function in mice. After continuously intragastric 
administration of RXLDDT 0.42 g·kg-1 for 7 days, the mice 
thymus weight increased significantly. Feet pad delay 
hypersensitivity reaction stimulated by Sheep Red Blood Cell 
(SRBC) increased by 52.2%183.0% and the proliferation of 
splenic lymphocytes increased by 94.6%274.1% in Con A-
stimulated mice. The phagocytosis of macrophages in mice 
was also significantly enhanced. RXLDDT could improve the 
nonspecific immunity, cell-mediated immunity and humoral 
immune function of mice treated with cyclophosphamide 
(CTX) [102]. S. Chamaejasme aqueous extract and alcohol 
extract could significantly inhibit the proliferation of T 
lymphocytes induced by the Con A. The ear swelling of 
Delayed Type Hypersensitivity (DTH) mice was significantly 
inhibited by the alcohol extract of S. Chamaejasme. Moreover 
the high concentration of alcohol extract was effective in 
inhibiting the index of animal thymic gland. The levels of 
interleukin-2 (IL-2) and interferon-γ (IFN-γ) in the laboratory 
animal serum were also markedly decreased. Therefore S. 
Chamaejasme could suppress cellular immunity by inhibiting 
activation of T cells and secretion of cytokines [103].  
4.7 Insecticidal activity   
Chemical pesticides pose a a health and environmental 
challenge and  and It is imperative to develop biorational 
pesticides for human, livestock and environmental safety. The 
insecticidal activity of S. Chamaejasme has been well 
established. The root of S. Chamaejasme was grinded into fine 
powder, and then placed it in the ditch to kill the underground 
  
pests, such as armyworm and fly. The bioactive analysis for 
the asian corn borer by S. Chamaejasme displayed that the 
death of the larvae was due to the toxicity and anti-feeding 
effect of the drug [104]. S. Chamaejasme had contagious and 
systemic toxicity to the hawthorn spider mite. Many plants 
have been proved to be of insecticidal properties, but only a 
few had acaricidal activity. S. Chamaejasme has the potential 
to become plant pest control agent however, further research 
is needed in this area [105]. 
5. TOXICITY  
S. Chamaejasme is a poisonous plant with the root being 
the most toxic. Cattle and sheep are prone to poisoning by 
accidental consumption of this plant. It Can cause vomiting, 
abdominal pain, diarrhea, limb weakness, whole body spasm, 
heart palpitations, and hyperthyroidism. In severe cases, 
collapse or convulsion of death can take place and in addition 
it can cause miscarriage if the female livestock comes into 
contact with S. Chamaejasme.  Human contact can result in 
allergic dermatitis And its pollen can induce a strong and 
persistent spicy irritation to the eyes, nose and throat [106]. 
Therefore contact with S. Chamaejasme  with must be kept to 
a minimum and managed carefully..  
The LD50 value was 184.3 g/kg of SCLA, and SCLA was 
found to be almost nontoxic [84]. The LD50 value was 2.08 
g/kg of ethanol extract of S. Chamaejasme, the mice were 
shown to be physically weak, curled up all over their bodies, 
twitched, struggled and even died, revealing that the drug was 
somewhat toxic [107]. The total extract of S. Chamaejasme, 
petroleum ether extract of S. Chamaejasme, ethyl acetate 
extract of S. Chamaejasme and n-butyl alcohol extract of S. 
Chamaejasme were subjected to acute toxicity experiments. 
These proved that that the ethyl acetate extract displayed the 
highest toxicity under the same dose of different polar parts, 
and the LD50 of the ethyl acetate extract was 4.66 g/kg.. These 
experiments also indicate that the the toxicity of different 
extracts of S. Chamaejasme are different [108]. No toxicity 
was found when neochamaejasmin B (until 156.25 µM) was 
added to madin-darby canine kidney (MDCK) and MDCK-
human multidrug resistance gene 1 (hMDR1) cells for 3h. 
However its cytotoxicity was detected after 40 hours of 
continuous culture by MTT analysis (respectively n=3, 4), the 
IC50 was 20.60 µmol·L-1 for MDCK cells and 210.9 µmol·L-1 
for MDCK-hMDR1 cells [109]. 
6. CONCLUSION     
The flavonoids, coumarins, terpenoids, lignans and other 
chemical components have been isolated from S. 
Chamaejasme. Many of these monomer compounds have 
anticancer, antivirus, immunomodulatory, anti-inflammatory 
and other pharmacological activities. Therefore, it is possible 
to study the structure-activity relationship of these monomer 
compounds to find the lead compounds. In recent years, some 
more advanced extraction and separation technology, such as 
solid Phase extraction (SPE) and high-speed countercurrent 
chromatography (HSCCC), has been applied in the field of 
natural products, and one can apply this advanced technology 
for extraction and separation of chemical constituents of S. 
Chamaejasme. This will not only increase the separation 
efficiency, but also enhance the chance of discovery of new 
compounds. However the current pharmacological research of 
S. Chamaejasme has only been conducted in the evaluation of 
the pharmacodynamics of extracts and compounds, the direct 
mechanism of action and the targets need to be further 
explored. Although S. Chamaejasme is widely distributed, has 
a large density, is abundant and easy to obtain, the active 
constituents should be synthesized and developed. These 
compounds can then be evaluated for their pharmacological 
activities and in doing so will also protect the natural 
resources and be ecologically friendly. This synthetic 
approach will rationally utilize the natural resources and fully 
exploit the medicinal value of S. Chamaejasme.   
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